Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Sells $95,225.76 in Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Robert Desantis sold 188 shares of the company’s stock in a transaction dated Tuesday, October 29th. The shares were sold at an average price of $506.52, for a total transaction of $95,225.76. Following the transaction, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at approximately $2,788,899.12. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Robert Desantis also recently made the following trade(s):

• On Friday, October 25th, Robert Desantis sold 1,012 shares of Intuitive Surgical stock. The stock was sold at an average price of $514.00, for a total transaction of $520,168.00.
• On Tuesday, September 10th, Robert Desantis sold 238 shares of Intuitive Surgical stock. The shares were sold at an average price of $477.50, for a total transaction of $113,645.00.
• On Thursday, August 29th, Robert Desantis sold 188 shares of Intuitive Surgical stock. The stock was sold at an average price of $482.21, for a total value of $90,655.48.
• On Monday, August 26th, Robert Desantis sold 396 shares of Intuitive Surgical stock. The shares were sold at an average price of $486.88, for a total value of $192,804.48.
• On Monday, August 12th, Robert Desantis sold 240 shares of Intuitive Surgical stock. The shares were sold at an average price of $464.76, for a total value of $111,542.40.

Intuitive Surgical Stock Down 1.9 %

Shares of Intuitive Surgical stock opened at $503.84 on Friday. The business has a 50-day moving average price of $490.01 and a 200 day moving average price of $445.70. Intuitive Surgical, Inc. has a fifty-two week low of $260.17 and a fifty-two week high of $523.34. The firm has a market cap of $179.46 billion, a P/E ratio of 81.00, a P/E/G ratio of 5.11 and a beta of 1.39.

Wall Street Analyst Weigh In

Several research firms recently commented on ISRG. Mizuho raised their price target on shares of Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. BTIG Research set a $535.00 target price on shares of Intuitive Surgical in a report on Friday, October 18th. Oppenheimer reiterated a “market perform” rating on shares of Intuitive Surgical in a report on Friday, October 18th. Leerink Partners boosted their price objective on Intuitive Surgical from $489.00 to $502.00 in a research note on Thursday, October 17th. Finally, Wells Fargo & Company increased their target price on Intuitive Surgical from $466.00 to $549.00 and gave the company an “overweight” rating in a research note on Friday, October 18th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have given a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $513.74.

Institutional Investors Weigh In On Intuitive Surgical

Several institutional investors and hedge funds have recently made changes to their positions in ISRG. Creekmur Asset Management LLC increased its stake in Intuitive Surgical by 200.0% during the first quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 42 shares during the last quarter. Ridgewood Investments LLC bought a new stake in shares of Intuitive Surgical during the 2nd quarter valued at about $26,000. Delos Wealth Advisors LLC raised its stake in Intuitive Surgical by 380.0% during the first quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock worth $29,000 after acquiring an additional 57 shares during the period. Godsey & Gibb Inc. lifted its holdings in Intuitive Surgical by 140.0% in the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after acquiring an additional 35 shares during the last quarter. Finally, LRI Investments LLC acquired a new position in Intuitive Surgical in the first quarter valued at approximately $30,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.